EFFECTOR THERAPEUTICS INC - COM (EFTR)

CUSIP: 28202V108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
24,403,703
Share change
+818,715
Total reported value
$20,139,361
Put/Call ratio
3.2%
Price per share
$0.83
Number of holders
31
Value change
+$705,349
Number of buys
12
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 28202V108?
CUSIP 28202V108 identifies EFTR - EFFECTOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - COM (EFTR) as of Q2 2023

As of 30 Jun 2023, EFFECTOR THERAPEUTICS INC - COM (EFTR) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,403,703 shares. The largest 10 holders included SR ONE CAPITAL MANAGEMENT, LP, Carlyle Group Inc., Column Group LLC, SECTORAL ASSET MANAGEMENT INC, Parallel Advisors, LLC, Blackstone Inc., OUP Management Co., LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, and Sea Otter Advisors LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.